Abstract
STn (NeuAcα2→6GalNAcα-O-Ser/Thr) is a carbohydrate epitope overexpressed in various human carcinomas. Clinical trials are underway using synthetic STn or STn trimeric glycopeptides [STn, cluster; STn(c) conjugated with keyhole limpet hemocyanin (KLH) as active specific immunotherapy for these cancers. These vaccines have been prepared by conjugating a crotyl ethyl amide derivative of STn or STn(c) to KLH by direct reductive amination after ozonolysis. In the case of STn(c) the conjugation efficiency and the resulting epitope ratios were low. This may be due to steric hinderance of the short spacer arm. To overcome these difficulties, without resynthesis, the STn(c) glycopeptide was modified by attachment of an MMCCH (4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide) spacer arm to the aldehyde derivative, and then conjugated with thiolated KLH. This method gave a higher epitope ratio and yield than the direct method. The STn(c)-MMCCH-KLH conjugate induced high titer antibodies in mice against STn(c). This method may be generally applicable for large synthetic oligosaccharides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
O'Boyle KP, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, Lloyd KO, Oettgen HF, Old LJ, Livingston PO (1992) Cancer Res 52: 5663–7.
Adluri S, Helling F, Ogata S, Zhang S, Itzkowitz SH, Lloyd KO, Livingston PO (1995) Cancer Immunol Immunother 41: 185–92.
MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM (1993) Cancer Immunol Immunother 36: 215–22.
Longenecker BM, Reddish M, Miles D, MacLean GD (1993) Vaccine Res 2: 151–62.
Ragupathi G (1996) Cancer Immunol Immunother 43: 152–57.
Ragupathi G, Park TK, Zhang S, Kim IJ, Graber L, Adluri S, Lloyd KO, Danishefsky SJ, Livingston PO (1997) Angew Chem Int Ed Engl 36: 125–8.
Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS (1990) Cancer 66: 1960–6.
Itzkowitz SH, Kjeldsen T, Friera A, Hakomori S, Yang U, Kim YS (1991) Gastroenterology 100: 1691–700.
Werther JL, Rivera-MacMurry S, Bruckner HB, Tatematsu M, Itzkowitz SH (1994) Br J Cancer 69: 613–16.
Thor A, Ohuchi N, Szpak CA, Johnson WW, Schlom J (1986) Cancer Res 46: 3118–24.
Xu M, Real FX, Welt S, Schussler MH, Oettgen HF, Old LJ (1989) Int J Cancer 44: 985–9.
Zhang S, Walberg LA, Ogata S, Itzkowitz SH, Koganty RR, Reddish M, Gandhi SS, Longenecker MB, Lloyd KO, Livingston PO (1995) Cancer Res 55: 3364–8.
Svennerholm L (1957) Biochem Biophys Acta 24: 604–11.
Riddles PW, Blackeley RL, Zerner B (1979) Anal Biochem 94: 75–81.
Kensil CR, Patel U, Lennick M, Marciani D (1991) J Immunol 146: 431–7.
Swerdlow RD, Ebert RF, Lee P, Bonaventura C, Miller KI (1996) Comp Biochem Physiol 113B: 537–48.
Landsteiner K (1945) In The Specificity of Serological Reactions. Cambridge, Massachusetts: Harvard University Press.
Klaus GG, Cross AM (1974) Cell Immunol 14: 226–41.
Williams DG (1986) In Immunoassay Technology, (Pal SB, ed.) Vol 2, pp 1–15 Berlin: Walter de Gruyter & Co.
Erlanger BF (1973) Pharmacol Rev 25: 271–80.
Helling F, Shang A, Claves M, Zhang S, Ren S, Yu RK, Oettgen HF, Livingston PO (1994) Cancer Res 54: 197–203.
Helling F, Zhang S, Shang A, Adluri S, Calves M, Koganty R, Longenecker BM, Yao TJ, Oettgen HF, Livingston PO (1995) Cancer Res 55: 2783–8.
Lindner HR, Perel E, Friedlander A, Zeitlin A (1972) Steroids 19: 357–75.
Exley D, Johnson MW, Dean PDG (1971) Steroids 18: 605–20.
Jeffcoate SL, Searle JE (1972) Steroids 19: 181–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ragupathi, G., Rao Koganty, R., Qiu, D. et al. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm. Glycoconj J 15, 217–221 (1998). https://doi.org/10.1023/A:1006936826730
Issue Date:
DOI: https://doi.org/10.1023/A:1006936826730